33 studies found for:
" September 22, 2010":" October 22, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Recruiting |
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
|
||||
| 22 | Active, not recruiting |
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
|
||||
| 23 | Completed |
GSK1349572 Hepatic Impairment Study
|
||||
| 24 | Completed |
A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects
|
||||
| 25 | Recruiting |
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
|
||||
| 26 | Active, not recruiting |
Young Women's CoOp Study
|
||||
| 27 | Recruiting |
Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
|
||||
| 28 | Unknown † |
Safety Study of Raltegravir in HIV/HCV Co-infected Patients
|
||||
| 29 | Completed |
Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
|
||||
| 30 | Recruiting |
EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
|
||||
| 31 | Completed |
Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects
|
||||
| 32 | Active, not recruiting |
Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children
|
||||
| 33 | Completed |
Family Planning Through Dairy Cooperatives
|
† Indicates status has not been verified in more than two years
